Thu, December 10, 2009
Wed, December 9, 2009
Tue, December 8, 2009
Mon, December 7, 2009
Sun, December 6, 2009
Fri, December 4, 2009
Thu, December 3, 2009
Wed, December 2, 2009
Tue, December 1, 2009
Mon, November 30, 2009
Fri, November 27, 2009
Thu, November 26, 2009
Wed, November 25, 2009
Tue, November 24, 2009
Mon, November 23, 2009
Sun, November 22, 2009
Fri, November 20, 2009
Thu, November 19, 2009
Wed, November 18, 2009
Tue, November 17, 2009
Mon, November 16, 2009
Sun, November 15, 2009
Fri, November 13, 2009
Thu, November 12, 2009
Wed, November 11, 2009
Tue, November 10, 2009
Mon, November 9, 2009
Fri, November 6, 2009
Thu, November 5, 2009
Wed, November 4, 2009
Tue, November 3, 2009
Mon, November 2, 2009
Sun, November 1, 2009
Fri, October 30, 2009
Thu, October 29, 2009
Wed, October 28, 2009
Tue, October 27, 2009
Mon, October 26, 2009

BioSyntech announces second quarter fiscal 2010 financial results


//health-fitness.news-articles.net/content/2009/ .. econd-quarter-fiscal-2010-financial-results.html
Published in Health and Fitness on Friday, November 13th 2009 at 11:02 GMT by Market Wire   Print publication without navigation


 - Appointed Ms. Jeanne M. Bertonis to the position of Chief Executive Officer and Ms. Antoinette Lizzi to the position of Chief Financial Officer. - Raised $1.4 million in a non-brokered private placement consisting of 140,000 units of BioSyntech, each comprised of $10 principal amount of subordinated secured convertible debentures and 91 common share purchase warrants at a price of $10 per Unit. - Subsequent to quarter-end, closed rights offering for gross aggregate proceeds of $3.1 million. - Interim analysis of clinical data from 41 patients in the ongoing Canadian/European clinical trial is being finalized, including MRI data. 

Publication Contributing Sources